Most sold healthcare stocks in Q1 2025
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2025, measured as net reductions in reported share positions from Q4 2024 into Q1 2025. Notable reductions at the top of this list include LIFESTANCE HEALTH GROUP INC (LFST), HALEON PLC-ADR (HLN), NOVO-NORDISK A/S-SPONS ADR (NVO), OSCAR HEALTH INC - CLASS A (OSCR). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LFST | LIFESTANCE HEALTH GROUP INC | -8,752,026 | -$66.03M | 0 | 2 | 0 | 1 | 2 |
| HLN | HALEON PLC-ADR | -8,605,834 | $47.82M | 0 | 2 | 4 | 0 | 6 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -6,562,989 | -$731.39M | 0 | 2 | 2 | 0 | 6 |
| OSCR | OSCAR HEALTH INC - CLASS A | -6,033,164 | -$83.07M | 0 | 0 | 2 | 2 | 3 |
| ACCD | ACCOLADE INC | -4,550,864 | -$14.07M | 0 | 1 | 0 | 1 | 1 |
| ZOM | ZOMEDICA CORP | -4,335,591 | -$520.27K | 0 | 0 | 0 | 2 | 0 |
| AVTR | AVANTOR INC | -4,323,178 | -$603.17M | 0 | 2 | 2 | 2 | 4 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -4,267,765 | -$288.63M | 1 | 2 | 2 | 1 | 7 |
| BBIO | BRIDGEBIO PHARMA INC | -3,065,616 | $73.13M | 0 | 0 | 1 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | -2,356,289 | -$247.23M | 0 | 2 | 8 | 0 | 15 |
| COO | COOPER COS INC/THE | -2,142,880 | -$197.15M | 0 | 0 | 1 | 2 | 2 |
| SNY | SANOFI-ADR | -1,962,806 | $442.51M | 1 | 3 | 1 | 0 | 5 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -1,815,404 | $43.41M | 0 | 0 | 2 | 0 | 3 |
| PRME | PRIME MEDICINE INC | -1,607,461 | -$7.99M | 1 | 0 | 1 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | -1,298,303 | $63.73M | 0 | 4 | 5 | 0 | 11 |
| KPTI | KARYOPHARM THERAPEUTICS INC | -1,202,590 | -$813.31K | 0 | 0 | 0 | 1 | 0 |
| DOCS | DOXIMITY INC-CLASS A | -1,197,132 | -$44.17M | 0 | 3 | 0 | 1 | 3 |
| DVA | DAVITA INC | -1,188,171 | -$57.50M | 0 | 0 | 2 | 1 | 2 |
| TRVI | TREVI THERAPEUTICS INC | -1,183,708 | $2.32M | 0 | 0 | 2 | 0 | 2 |
| CAH | CARDINAL HEALTH INC | -1,087,369 | -$115.73M | 0 | 1 | 2 | 0 | 4 |
| CRL | CHARLES RIVER LABORATORIES | -1,045,126 | -$230.50M | 0 | 1 | 1 | 2 | 2 |
| ELEV | ELEVATION ONCOLOGY INC | -956,009 | -$734.31K | 0 | 0 | 1 | 0 | 1 |
| MRK | MERCK & CO. INC. | -936,380 | -$116.92M | 0 | 3 | 7 | 1 | 12 |
| RPTX | REPARE THERAPEUTICS INC | -924,313 | -$1.67M | 0 | 0 | 2 | 0 | 2 |
| NVAX | NOVAVAX INC | -902,283 | -$8.08M | 0 | 0 | 1 | 0 | 1 |
| TSHA | TAYSHA GENE THERAPIES INC | -878,448 | -$1.52M | 0 | 0 | 0 | 1 | 0 |
| FGEN | FIBROGEN INC | -877,447 | -$570.29K | 0 | 0 | 1 | 0 | 1 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | -824,100 | -$1.81M | 0 | 0 | 1 | 0 | 1 |
| GILD | GILEAD SCIENCES INC | -803,927 | $699.19M | 0 | 2 | 5 | 1 | 7 |
| NVS | NOVARTIS AG-SPONSORED ADR | -774,138 | $125.45M | 0 | 2 | 4 | 0 | 6 |
| SYK | STRYKER CORP | -759,699 | -$148.54M | 0 | 1 | 6 | 0 | 7 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -745,200 | -$2.42M | 0 | 0 | 1 | 0 | 1 |
| EWTX | EDGEWISE THERAPEUTICS INC | -734,951 | -$21.93M | 0 | 0 | 1 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -712,664 | -$1.00M | 0 | 0 | 1 | 0 | 1 |
| ALHC | ALIGNMENT HEALTHCARE INC | -708,365 | $33.65M | 0 | 1 | 1 | 0 | 2 |
| OM | OUTSET MEDICAL INC | -686,748 | -$762.29K | 0 | 0 | 0 | 1 | 0 |
| RDY | DR. REDDY'S LABORATORIES-ADR | -627,709 | -$34.39M | 0 | 0 | 3 | 0 | 3 |
| ESPR | ESPERION THERAPEUTICS INC | -578,800 | -$1.27M | 0 | 0 | 0 | 1 | 0 |
| HOLX | HOLOGIC INC | -557,400 | -$83.46M | 0 | 3 | 4 | 0 | 7 |
| ACHL | ACHILLES THERAPEUTICS PL-ADR | -547,233 | -$623.85K | 0 | 0 | 0 | 1 | 0 |
| FOLD | AMICUS THERAPEUTICS INC | -546,623 | -$7.12M | 0 | 0 | 1 | 0 | 1 |
| CDNA | CAREDX INC | -492,218 | -$24.86M | 0 | 0 | 3 | 0 | 3 |
| CRDF | CARDIFF ONCOLOGY INC | -483,090 | -$2.10M | 0 | 0 | 0 | 1 | 0 |
| EXEL | EXELIXIS INC | -470,600 | $38.06M | 0 | 1 | 1 | 0 | 2 |
| DHR | DANAHER CORP | -452,791 | -$280.23M | 3 | 2 | 3 | 1 | 12 |
| ABT | ABBOTT LABORATORIES | -449,320 | $223.67M | 0 | 2 | 4 | 1 | 9 |
| PAHC | PHIBRO ANIMAL HEALTH CORP-A | -431,450 | -$8.55M | 0 | 1 | 1 | 0 | 2 |
| EDIT | EDITAS MEDICINE INC | -418,084 | -$644.59K | 0 | 0 | 1 | 0 | 1 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -417,074 | -$269.72K | 0 | 2 | 0 | 1 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | -411,274 | -$347.28M | 0 | 4 | 6 | 1 | 12 |
Frequently asked questions about Most sold healthcare stocks in Q1 2025
What are the most sold Healthcare stocks in Q1 2025?
The most sold healthcare stocks in Q1 2025 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q4 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2025?
Among the managers we track, net reductions were largest in companies such as LIFESTANCE HEALTH GROUP INC (LFST), HALEON PLC-ADR (HLN), NOVO-NORDISK A/S-SPONS ADR (NVO), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2024).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.